Recurrent episodes of isolated periorbital angioedema associated with separate courses of ibuprofen: A diagnostic dilemma

Author:

Sareen Kunal1,Singh Abhishek2,Aehmad Vaseem3,Raman Nishant4

Affiliation:

1. Intensive Care Unit, Sant Parmanand Hospital, Delhi, India

2. Department of Pathology, Military Hospital Dinjan, Dibrugarh, Assam, India

3. Department of Accident and Emergency, Military Hospital Babina, Jhansi, Uttar Pradesh, India

4. Department of Accident and Emergency, Central MIR, Border Roads Organisation, Roing, Arunachal Pradesh, India

Abstract

Drug hypersensitivity reactions (DHRs) to nonsteroidal anti-inflammatory drugs (NSAIDs) presenting as isolated periorbital angioedema (PE), especially that caused by Ibuprofen have not been extensively reported in the persons of Indian ethnicity. A 58-year-old Indian male was prescribed tablet Ibuprofen for lower backache. Shortly after intake of the tablet, the patient developed severe itching, redness, and watering in both eyes followed by bilateral progressive PE, without involvement of skin elsewhere, or the respiratory system, and in the absence of features suggestive of severe anaphylaxis. The episode was successfully managed with parenteral hydrocortisone and pheniramine. The patient disclosed two similar episodes previously on intake of ibuprofen which were also treated conservatively. Based on a score of 10 on the Naranjo Adverse Drug Reaction Probability Scale and oral Ibuprofen challenge test (OCT) that resulted in recurrence of a similar reaction, a definitive diagnosis of drug reaction to Ibuprofen was concluded. Raised serum immunoglobulin-E levels and eosinophilia on peripheral blood smear were other significant findings. Skin-prick test (SPT) with commonly used NSAIDs was inconclusive. A negative Aspirin/5-Acetyl Salicylic-Acid (ASA) OCT strongly supported the possibility of single-NSAID induced urticaria/angioedema or anaphylaxis reaction to Ibuprofen. This case report highlights the challenges in identifying and characterizing an NSAID-DHRs, especially in the background of varied clinical presentations and discordant test results, as well as due to the lack of well-established standards for SPT, absence of validated in vitro tests, nonavailability of test reagents, and risks associated with OCT.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3